Additionally, TIGIT+ Tregs enhanced the expression of the coinhibitory receptor T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) within tumor tissue (Joller et al., 2024). This evidence concerns the gene HAVCR2 and neoplasm.